Bortezomib Induction and Maintenance Treatment Improves Survival In Patients With Newly Diagnosed Multiple Myeloma:Extended Follow-Up Of The HOVON-65/GMMG-HD4 Trial

被引：10
|
作者：
Sonneveld, Pieter
Scheid, Christof
van der Holt, Bronno
el Jarari, Laila
Bertsch, Uta
Salwender, Hans
Zweegman, Sonja
Vellenga, Edo
Broyl, Annemiek
Blau, Igor Wolfgang
Weisel, Katja
Wittebol, Shulamit
Bos, Gerard M. J.
Stevens, Marjan
Schmidt-Wolf, Ingo G. H.
Pfreundschuh, Michael
Hose, Dirk
Jauch, Anna
van de Velde, Helgi
Raymakers, Reinier
Schaafsma, Martyn Ronald
Kersten, Marie Jose
Kooy, Marinus van Marwijk
Duehrsen, Ulrich
Lindemann, Hans Walter
Wijermans, Pierre W.
Lokhorst, Henk
Goldschmidt, H.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.404.404
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
404
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
    Mai, Elias K.
    Bertsch, Uta
    Pozek, Ema
    Fenk, Roland
    Besemer, Britta
    Hanoun, Christine
    Schroers, Roland
    von Metzler, Ivana
    Haenel, Mathias
    Mann, Christoph
    Leypoldt, Lisa B.
    Heilmeier, Bernhard
    Huhn, Stefanie
    Vogel, Sabine K.
    Hundemer, Michael
    Scheid, Christof
    Blau, Igor W.
    Luntz, Steffen
    Weinhold, Niels
    Tichy, Diana
    Holderried, Tobias A. W.
    Trautmann-Grill, Karolin
    Gezer, Deniz
    Klaiber-Hakimi, Maika
    Mueller, Martin
    Shumilov, Evgenii
    Knauf, Wolfgang
    Michel, Christian S.
    Geer, Thomas
    Riesenberg, Hendrik
    Lutz, Christoph
    Raab, Marc S.
    Benner, Axel
    Hoffmann, Martin
    Weisel, Katja C.
    Salwender, Hans J.
    Goldschmidt, Hartmut
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (11)
  • [32] Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma
    Joseph, Nisha S.
    Kaufman, Jonathan L.
    Dhodapkar, Madhav, V
    Hofmeister, Craig C.
    Almaula, Dhwani K.
    Heffner, Leonard T.
    Gupta, Vikas A.
    Boise, Lawrence H.
    Lonial, Sagar
    Nooka, Ajay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) : 1928 - +
  • [33] Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma
    Jagannath, Sundar
    Durie, Brian G. M.
    Wolf, Jeffrey Lee
    Camacho, Elber S.
    Irwin, David
    Lutzky, Jose
    McKinley, Marti
    Potts, Phyllis
    Gabayan, Afshin Eli
    Mazumder, Amitabha
    Crowley, John
    Vescio, Robert
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (06) : 619 - 626
  • [34] Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial
    Smits, Febe
    Groen, Kaz
    Levin, Mark-David
    Stege, Claudia A. M.
    Kampen, Roel J. W. van
    van der Spek, Ellen
    Bilgin, Yavuz M.
    Thielen, Noortje
    Nijhof, Inger S.
    Ludwig, Inge
    Waal, Esther G. M. De
    Sandberg, Yorick
    Kentos, Alain
    Timmers, Gert Jan
    Regelink, Josien C.
    Westerman, Matthijs
    de Heer, Koen
    Vekemans, Marie Christiane
    Durdu-Rayman, Nazik
    de Graauw, Nicole
    Seefat, Maarten R.
    Donk, Niels W. C. J. van de
    Ypma, Paula F.
    Nasserinejad, Kazem
    Zweegman, Sonja
    BLOOD, 2024, 144 : 4739 - 4740
  • [35] Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma-4-Year-Follow-Up from the GMMG-CONCEPT trial
    Leypoldt, Lisa
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc-Steffen
    Mann, Christoph
    Michel, Christian S.
    Reinhardt, Hans Christian
    Blau, Igor Wolfgang
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S33 - S34
  • [36] Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up
    Nishiyama, Risa
    Kagoo, Toshiya
    Ueno, Hironori
    Yokoyama, Akihiro
    IN VIVO, 2025, 39 (01): : 340 - 345
  • [37] Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
    Kumar, Shaji K.
    Berdeja, Jesus G.
    Niesvizky, Ruben
    Lonial, Sagar
    Laubach, Jacob P.
    Hamadani, Mehdi
    Stewart, A. Keith
    Hari, Parameswaran
    Roy, Vivek
    Vescio, Robert
    Kaufman, Jonathan L.
    Berg, Deborah
    Liao, Eileen
    Rajkumar, S. Vincent
    Richardson, Paul G.
    LEUKEMIA, 2019, 33 (07) : 1736 - 1746
  • [38] Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
    Shaji K. Kumar
    Jesus G. Berdeja
    Ruben Niesvizky
    Sagar Lonial
    Jacob P. Laubach
    Mehdi Hamadani
    A. Keith Stewart
    Parameswaran Hari
    Vivek Roy
    Robert Vescio
    Jonathan L. Kaufman
    Deborah Berg
    Eileen Liao
    S. Vincent Rajkumar
    Paul G. Richardson
    Leukemia, 2019, 33 : 1736 - 1746
  • [39] Lenalidomide Induction and Maintenance Maximizes Outcome for Newly Diagnosed Transplant Eligible Myeloma Patients Irrespective of Risk Status: Long-Term Follow-up of the Myeloma XI Trial
    Jackson, Graham
    Pawlyn, Charlotte
    Cairns, David
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Russell, Nigel H.
    Jenner, Matthew
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Gregory, Walter M.
    Kaiser, Martin F.
    Davies, Faith E.
    Morgan, Gareth
    BLOOD, 2019, 134
  • [40] Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial
    Mateos, Maria-Victoria
    Engelhardt, Monika
    Leleu, Xavier
    Mesa, Mercedes Gironella
    Cavo, Michele
    Dimopoulos, Meletios
    Bianco, Martina
    Merlo, Giovanni Marino
    Porte, Charles la
    Richardson, Paul G.
    Moreau, Philippe
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (02) : 242 - 252
12345